Psychemedics Corporation (PMD)
USD 2.67
(0.0%)
USD 2.67
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.41 Million USD | -9.45% |
| 2022 | 9.29 Million USD | -9.48% |
| 2021 | 10.26 Million USD | 110.07% |
| 2020 | 4.88 Million USD | -70.29% |
| 2019 | 16.44 Million USD | -20.24% |
| 2018 | 20.61 Million USD | 4.02% |
| 2017 | 19.82 Million USD | -7.59% |
| 2016 | 21.45 Million USD | 68.67% |
| 2015 | 12.71 Million USD | -15.99% |
| 2014 | 15.13 Million USD | -1.66% |
| 2013 | 15.39 Million USD | 8.02% |
| 2012 | 14.25 Million USD | -1.53% |
| 2011 | 14.47 Million USD | 20.19% |
| 2010 | 12.04 Million USD | 25.3% |
| 2009 | 9.6 Million USD | -28.02% |
| 2008 | 13.35 Million USD | -9.04% |
| 2007 | 14.67 Million USD | 4.42% |
| 2006 | 14.05 Million USD | 11.76% |
| 2005 | 12.57 Million USD | 20.37% |
| 2004 | 10.44 Million USD | 24.82% |
| 2003 | 8.37 Million USD | -7.51% |
| 2002 | 9.04 Million USD | 14.33% |
| 2001 | 7.91 Million USD | -23.34% |
| 2000 | 10.32 Million USD | -16.74% |
| 1999 | 12.4 Million USD | 10.71% |
| 1998 | 11.2 Million USD | 12.0% |
| 1997 | 10 Million USD | 29.87% |
| 1996 | 7.7 Million USD | 30.51% |
| 1995 | 5.9 Million USD | 9.26% |
| 1994 | 5.4 Million USD | 28.57% |
| 1993 | 4.2 Million USD | 75.0% |
| 1992 | 2.4 Million USD | 118.18% |
| 1991 | 1.1 Million USD | 57.14% |
| 1990 | 700 Thousand USD | 170.0% |
| 1989 | -1 Million USD | -400.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.12 Million USD | 3.11% |
| 2024 Q2 | 1.55 Million USD | -26.86% |
| 2023 Q4 | 2.05 Million USD | -1.58% |
| 2023 Q2 | 2.05 Million USD | -6.62% |
| 2023 Q1 | 2.2 Million USD | -1.78% |
| 2023 Q3 | 2.09 Million USD | 1.55% |
| 2023 FY | 8.41 Million USD | -9.45% |
| 2022 Q3 | 2.33 Million USD | 2.6% |
| 2022 Q1 | 2.44 Million USD | 11.72% |
| 2022 Q2 | 2.27 Million USD | -6.88% |
| 2022 Q4 | 2.24 Million USD | -3.73% |
| 2022 FY | 9.29 Million USD | -9.48% |
| 2021 Q4 | 2.18 Million USD | -28.94% |
| 2021 Q2 | 2.43 Million USD | -5.14% |
| 2021 Q3 | 3.07 Million USD | 26.23% |
| 2021 FY | 10.26 Million USD | 110.07% |
| 2021 Q1 | 2.56 Million USD | 101.1% |
| 2020 FY | 4.88 Million USD | -70.29% |
| 2020 Q4 | 1.27 Million USD | 12.71% |
| 2020 Q3 | 1.13 Million USD | 549.6% |
| 2020 Q2 | -252 Thousand USD | -109.24% |
| 2020 Q1 | 2.72 Million USD | -21.72% |
| 2019 FY | 16.44 Million USD | -20.24% |
| 2019 Q2 | 4.16 Million USD | -5.42% |
| 2019 Q3 | 4.38 Million USD | 5.11% |
| 2019 Q4 | 3.48 Million USD | -20.47% |
| 2019 Q1 | 4.4 Million USD | -6.87% |
| 2018 FY | 20.61 Million USD | 4.02% |
| 2018 Q2 | 5.17 Million USD | -3.42% |
| 2018 Q1 | 5.35 Million USD | 12.1% |
| 2018 Q3 | 5.35 Million USD | 3.6% |
| 2018 Q4 | 4.73 Million USD | -11.66% |
| 2017 FY | 19.82 Million USD | -7.59% |
| 2017 Q4 | 4.77 Million USD | -6.72% |
| 2017 Q1 | 5.31 Million USD | -16.91% |
| 2017 Q2 | 4.6 Million USD | -13.3% |
| 2017 Q3 | 5.12 Million USD | 11.11% |
| 2016 Q4 | 6.39 Million USD | -9.95% |
| 2016 FY | 21.45 Million USD | 68.67% |
| 2016 Q3 | 7.1 Million USD | 36.39% |
| 2016 Q2 | 5.2 Million USD | 90.22% |
| 2016 Q1 | 2.73 Million USD | 3.27% |
| 2015 Q2 | 3.26 Million USD | -2.07% |
| 2015 Q1 | 3.33 Million USD | -4.1% |
| 2015 FY | 12.71 Million USD | -15.99% |
| 2015 Q3 | 3.45 Million USD | 5.72% |
| 2015 Q4 | 2.65 Million USD | -23.29% |
| 2014 FY | 15.13 Million USD | -1.66% |
| 2014 Q1 | 3.79 Million USD | 3.94% |
| 2014 Q3 | 3.96 Million USD | 2.01% |
| 2014 Q4 | 3.48 Million USD | -12.29% |
| 2014 Q2 | 3.89 Million USD | 2.52% |
| 2013 Q4 | 3.65 Million USD | -12.55% |
| 2013 Q1 | 3.48 Million USD | 26.1% |
| 2013 Q3 | 4.17 Million USD | 2.38% |
| 2013 Q2 | 4.07 Million USD | 16.97% |
| 2013 FY | 15.39 Million USD | 8.02% |
| 2012 Q3 | 3.71 Million USD | -9.4% |
| 2012 Q2 | 4.1 Million USD | 11.96% |
| 2012 Q1 | 3.66 Million USD | 15.49% |
| 2012 FY | 14.25 Million USD | -1.53% |
| 2012 Q4 | 2.76 Million USD | -25.61% |
| 2011 Q3 | 3.94 Million USD | 5.49% |
| 2011 Q4 | 3.17 Million USD | -19.54% |
| 2011 Q1 | 3.61 Million USD | 17.35% |
| 2011 FY | 14.47 Million USD | 20.19% |
| 2011 Q2 | 3.73 Million USD | 3.37% |
| 2010 Q1 | 2.55 Million USD | 1.25% |
| 2010 Q4 | 3.08 Million USD | 1.85% |
| 2010 Q3 | 3.02 Million USD | -10.47% |
| 2010 FY | 12.04 Million USD | 25.3% |
| 2010 Q2 | 3.37 Million USD | 32.36% |
| 2009 FY | 9.6 Million USD | -28.02% |
| 2009 Q4 | 2.52 Million USD | -12.74% |
| 2009 Q3 | 2.89 Million USD | 37.25% |
| 2009 Q2 | 2.1 Million USD | 0.66% |
| 2009 Q1 | 2.09 Million USD | -19.53% |
| 2008 Q4 | 2.59 Million USD | -28.83% |
| 2008 Q2 | 3.77 Million USD | 13.67% |
| 2008 Q1 | 3.32 Million USD | -2.14% |
| 2008 FY | 13.35 Million USD | -9.04% |
| 2008 Q3 | 3.65 Million USD | -3.27% |
| 2007 Q1 | 3.26 Million USD | -4.04% |
| 2007 Q2 | 4.1 Million USD | 25.98% |
| 2007 Q3 | 3.91 Million USD | -4.85% |
| 2007 Q4 | 3.39 Million USD | -13.18% |
| 2007 FY | 14.67 Million USD | 4.42% |
| 2006 Q1 | 2.95 Million USD | 0.82% |
| 2006 Q4 | 3.39 Million USD | -11.83% |
| 2006 FY | 14.05 Million USD | 11.76% |
| 2006 Q3 | 3.85 Million USD | 0.15% |
| 2006 Q2 | 3.84 Million USD | 30.48% |
| 2005 Q3 | 3.08 Million USD | -8.99% |
| 2005 FY | 12.57 Million USD | 20.37% |
| 2005 Q4 | 2.92 Million USD | -5.16% |
| 2005 Q2 | 3.39 Million USD | 6.87% |
| 2005 Q1 | 3.17 Million USD | 30.17% |
| 2004 Q4 | 2.43 Million USD | -11.83% |
| 2004 FY | 10.44 Million USD | 24.82% |
| 2004 Q3 | 2.76 Million USD | -10.67% |
| 2004 Q2 | 3.09 Million USD | 43.87% |
| 2004 Q1 | 2.15 Million USD | 36.98% |
| 2003 Q4 | 1.57 Million USD | -34.88% |
| 2003 FY | 8.37 Million USD | -7.51% |
| 2003 Q3 | 2.41 Million USD | -3.43% |
| 2003 Q1 | 1.89 Million USD | 8.12% |
| 2003 Q2 | 2.49 Million USD | 32.05% |
| 2002 Q4 | 1.74 Million USD | -31.75% |
| 2002 Q1 | 1.81 Million USD | 28.88% |
| 2002 FY | 9.04 Million USD | 14.33% |
| 2002 Q2 | 2.92 Million USD | 60.98% |
| 2002 Q3 | 2.56 Million USD | -12.3% |
| 2001 Q4 | 1.4 Million USD | -28.9% |
| 2001 Q3 | 1.98 Million USD | -21.21% |
| 2001 FY | 7.91 Million USD | -23.34% |
| 2001 Q1 | 2.01 Million USD | 113.8% |
| 2001 Q2 | 2.51 Million USD | 25.01% |
| 2000 Q4 | 940.7 Thousand USD | -69.18% |
| 2000 Q2 | 3.46 Million USD | 21.08% |
| 2000 FY | 10.32 Million USD | -16.74% |
| 2000 Q1 | 2.86 Million USD | 19.34% |
| 2000 Q3 | 3.05 Million USD | -12.0% |
| 1999 Q1 | 3.1 Million USD | 19.23% |
| 1999 Q2 | 4 Million USD | 29.03% |
| 1999 Q3 | 3.1 Million USD | -22.5% |
| 1999 Q4 | 2.4 Million USD | -22.58% |
| 1999 FY | 12.4 Million USD | 10.71% |
| 1998 Q4 | 2.6 Million USD | -10.34% |
| 1998 Q1 | 2.6 Million USD | -3.7% |
| 1998 Q2 | 3.2 Million USD | 23.08% |
| 1998 FY | 11.2 Million USD | 12.0% |
| 1998 Q3 | 2.9 Million USD | -9.38% |
| 1997 Q1 | 2.1 Million USD | 10.53% |
| 1997 FY | 10 Million USD | 29.87% |
| 1997 Q2 | 3 Million USD | 42.86% |
| 1997 Q4 | 2.7 Million USD | 17.39% |
| 1997 Q3 | 2.3 Million USD | -23.33% |
| 1996 Q1 | 1.7 Million USD | 30.77% |
| 1996 FY | 7.7 Million USD | 30.51% |
| 1996 Q4 | 1.9 Million USD | -5.0% |
| 1996 Q3 | 2 Million USD | 0.0% |
| 1996 Q2 | 2 Million USD | 17.65% |
| 1995 Q2 | 1.6 Million USD | 23.08% |
| 1995 Q4 | 1.3 Million USD | -18.75% |
| 1995 Q3 | 1.6 Million USD | 0.0% |
| 1995 Q1 | 1.3 Million USD | -7.14% |
| 1995 FY | 5.9 Million USD | 9.26% |
| 1994 Q3 | 1.6 Million USD | 6.67% |
| 1994 Q4 | 1.4 Million USD | -12.5% |
| 1994 FY | 5.4 Million USD | 28.57% |
| 1994 Q2 | 1.5 Million USD | 87.5% |
| 1994 Q1 | 800 Thousand USD | -42.86% |
| 1993 Q1 | 600 Thousand USD | -45.45% |
| 1993 Q2 | 1.1 Million USD | 83.33% |
| 1993 Q3 | 1 Million USD | -9.09% |
| 1993 Q4 | 1.4 Million USD | 40.0% |
| 1993 FY | 4.2 Million USD | 75.0% |
| 1992 FY | 2.4 Million USD | 118.18% |
| 1992 Q3 | 1.2 Million USD | 20.0% |
| 1992 Q2 | 1 Million USD | 150.0% |
| 1992 Q1 | 400 Thousand USD | -42.86% |
| 1992 Q4 | 1.1 Million USD | -8.33% |
| 1991 FY | 1.1 Million USD | 57.14% |
| 1991 Q3 | 700 Thousand USD | 16.67% |
| 1991 Q4 | 700 Thousand USD | 0.0% |
| 1991 Q2 | 600 Thousand USD | 200.0% |
| 1991 Q1 | 200 Thousand USD | -66.67% |
| 1990 Q3 | 600 Thousand USD | 50.0% |
| 1990 Q2 | 400 Thousand USD | 100.0% |
| 1990 FY | 700 Thousand USD | 170.0% |
| 1990 Q1 | 200 Thousand USD | 0.0% |
| 1990 Q4 | 600 Thousand USD | 0.0% |
| 1989 Q2 | 100 Thousand USD | -66.67% |
| 1989 Q3 | 100 Thousand USD | 0.0% |
| 1989 FY | -1 Million USD | -400.0% |
| 1989 Q1 | 300 Thousand USD | 50.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bionano Genomics, Inc. | 9.56 Million USD | 12.053% |
| Prenetics Global Limited | 8.82 Million USD | 4.721% |
| Star Equity Holdings, Inc. | 11.92 Million USD | 29.457% |
| CareDx, Inc | 178.32 Million USD | 95.282% |
| Exact Sciences Corporation | 1.84 Billion USD | 99.544% |
| Exagen Inc. | 29.45 Million USD | 71.439% |
| Inotiv, Inc. | 165.44 Million USD | 94.915% |
| Guardant Health, Inc. | 336.89 Million USD | 97.503% |
| Biodesix, Inc. | 36.07 Million USD | 76.68% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -532.795% |
| Precipio, Inc. | 6.01 Million USD | -39.797% |
| iSpecimen Inc. | 5.1 Million USD | -64.705% |
| Natera, Inc. | 492.74 Million USD | 98.293% |
| Aspira Women's Health Inc. | 5.26 Million USD | -59.882% |
| Standard BioTools Inc. | 50.45 Million USD | 83.324% |
| 23andMe Holding Co. | 99.37 Million USD | 91.534% |
| Castle Biosciences, Inc. | 174.8 Million USD | 95.187% |
| Personalis, Inc. | 18.2 Million USD | 53.795% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | 36.11% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -52.039% |
| OpGen, Inc. | -90.69 Thousand USD | 9376.248% |
| T2 Biosystems, Inc. | -8.17 Million USD | 202.974% |
| Myriad Genetics, Inc. | 476.4 Million USD | 98.234% |
| ICON Public Limited Company | 1.81 Billion USD | 99.536% |
| NeoGenomics, Inc. | 244.6 Million USD | 96.561% |
| Star Equity Holdings, Inc. | 11.92 Million USD | 29.457% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 99.616% |
| RadNet, Inc. | 93 Million USD | 90.954% |
| MDxHealth SA | 43.92 Million USD | 80.849% |
| Illumina, Inc. | 2.74 Billion USD | 99.693% |
| Check-Cap Ltd. | -212 Thousand USD | 4068.396% |
| Twist Bioscience Corporation | 133.34 Million USD | 93.691% |
| DarioHealth Corp. | 5.98 Million USD | -40.592% |
| Fulgent Genetics, Inc. | 104.45 Million USD | 91.946% |
| Sera Prognostics, Inc. | 96 Thousand USD | -8663.542% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 3154.264% |
| OPKO Health, Inc. | 318.12 Million USD | 97.355% |
| Medpace Holdings, Inc. | 524.5 Million USD | 98.396% |
| Neogen Corporation | 463.9 Million USD | 98.186% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -490.127% |
| Prenetics Global Limited | 8.82 Million USD | 4.721% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -1550.712% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -962.764% |
| Trinity Biotech plc | 19.45 Million USD | 56.746% |
| Neuronetics, Inc. | 51.7 Million USD | 83.729% |
| Sotera Health Company | 577.15 Million USD | 98.542% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -962.764% |